BIO-key International (NASDAQ) is a biometric identity and access management solution provider. It has developed key innovations in IDaaS cloud offerings to meet growing IT security needs and cybercrime demand. However, given the company’s negative profit margin and unstable financials, will it be able to maintain its market standing and keep attracting investors’ attention? Let’s find out.Identity and access management (IAM) platform BIO-key International, Inc. (BKYI) offers fingerprint identification biometric technology to commercial, government, and education customers in the United States and worldwide. Growing demand for BKYI’s PortalGuard cloud-hosted IDaaS solution and expanded customer reach through its Channel Alliance Partner (CAP) program have garnered investors’ attention, as evident from the stock’s 13.6% gains over the past month.

The stock’s share price has fallen 8.7% in the last three months. While BKYI’s continued investment in product development and innovation should strengthen its position in the market as the need for enhanced digital protection has never been greater than now, its negative profit margin could make investors nervous.

Here’s what could influence BKYI’s performance in the coming months:

Continue reading on StockNews